SEC Form 4 · accession 0001144204-15-032121
Jaguar Health, Inc. · JAGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
BVCF III, L.P.
10% Owner
Kunlun Pharmaceuticals, Ltd.
10% Owner
BVCF Management, Ltd.
10% Owner
BVCF III-A, L.P.
10% Owner
Period of report
May 18, 2015
Accepted (ET)
May 18, 2015 · 6:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001585608
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 18, 2015 | C | 1,483,326 | — | A | 1,522,881 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Preferred StockF2,F1 | — | May 18, 2015 | C | 2,224,991 | D | — | — | Common Stock | 1,483,326 | 0 | I |
Explanation of responses
- F1These securities automatically converted into Issuer's common stock on a 1.5 to 1 basis immediately prior to the consummation of Issuer's initial public offering ("IPO") and had no expiration date.
- F2Represents (i) 39,555 shares held by Sichuan Biopharma ("Sichuan") and (ii) 1,488,326 shares held by Kunlun Pharmaceuticals, Ltd. ("Kunlun"). Sichuan is an investment vehicle of BVCF Management, Ltd. ("BVCF"). Kunlun is directly owned by BVCF III, L.P. and BVCF III-A, L.P. BVCF III, L.P. and BVCF III-A, L.P. are managed by BVCF. Zhi Yang is Chairman, Founder, Managing Partner and sole shareholder of BVCF and may be deemed to have sole voting and dispositive power with respect to the shares held by Sichuan and Kunlun. Zhi Yang disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.